Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000919574-18-006350
Filing Date
2018-09-27
Accepted
2018-09-27 16:25:31
Documents
1
Period of Report
2018-09-20

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 15130
  Complete submission text file 0000919574-18-006350.txt   17726
Mailing Address 11975 EL CAMINO REAL, SUITE 300 SAN DIEGO, CA 92130
Business Address 11975 EL CAMINO REAL, SUITE 300 SAN DIEGO, CA 92130 (858) 222-8041
APRICUS BIOSCIENCES, INC. (Issuer) CIK: 0001017491 (see all company filings)

EIN.: 870449967 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 510 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10022
Business Address 510 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10022 (212) 231-4932
ARMISTICE CAPITAL, LLC (Reporting) CIK: 0001601086 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 000-22245 | Film No.: 181091217

Mailing Address C/O ARMISTICE CAPITAL, LLC 510 MADISON AVENUE, 22ND FLOOR NEW YORK NY 10022
Business Address C/O ARMISTICE CAPITAL, LLC 510 MADISON AVENUE, 22ND FLOOR NEW YORK NY 10022 212-231-4932
Armistice Capital Master Fund Ltd. (Reporting) CIK: 0001633584 (see all company filings)

State of Incorp.: E9 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 000-22245 | Film No.: 181091218

Mailing Address 510 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10022
Business Address
Boyd Steven (Reporting) CIK: 0001706140 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-22245 | Film No.: 181091219